Nature Against Cancer: When Plants Write Their Own Medicine

By: Ashley Sheyn B. Buising | Paralogon

Nature is not wearing white coats nor publishing discoveries. Yet for millions of years, plants have been designing complex biological solutions within their genes. Every part carries instructions. Every cell follows a blueprint. And hidden within this blueprint may be weapons against one of humanity’s most formidable diseases: cancer. 

Cancer begins with a mutation in the genetic instructions.  Cells may begin dividing uncontrollably, ignoring the individual’s signals to stop.  Plants live very different lives from humans. They cannot flee from insects that chew their leaves or pathogens that invade their tissues. Rooted in the soil, immobility is the plants’ biggest weakness. But adaptation is survival. They survive by building systems at the molecular level. Through evolution, the genetic imprint of plants learned to craft intricate chemicals that repel threats, control damage, and regulate growth.

Mitraphylline is one of nature’s created rare chemicals, a molecule that has captured scientists’ attention for its high potential to help fight cancer. Mitraphylline is produced by certain tropical plants, including the species of Mitragyna and Uncaria, members of the same botanical family as coffee. Being small and infamous, the molecule has drawn attention for its potential anti-cancer and anti-inflammatory properties in its structure. Early studies suggest it may interact with the cellular pathways that are linked to tumor development, making it a best candidate for further exploration.

               One discovery led to another. To scientists, mitraphylline is a great chemical in molecular engineering. Its structure belongs to the rare class of compounds known as spirooxindole alkaloids, defined by its unusual twisted shapes. It resembles a molecular knot because its structure consists of two rings of atoms intersecting at a single point. Scientists began studying plant genetics to trace the cellular pathway. By examining which genes were active in plants that may be able to produce the spirooxindole alkaloids.

But it was still incomplete. The scientists were not yet done, they revealed two additional enzymes responsible for shaping mitraphylline during its final stages of construction. First, the enzyme that makes the spiro structure was identified, positioning its atoms in the precise orientation that is required for the next transformation. And another enzyme actually performs the dramatic finishing move, twisting the molecular feature that gives this family of compounds its name into its final form. It was the first glimpse of the plant’s blueprint.

Together, these enzymes represent pieces of the genetic blueprint that plants follow to build mitraphylline inside their cells. For researchers, decoding this blueprint opens new possibilities. The fact that plants only produce a tiny amount of  mitraphyllin, obtaining enough of it for extensive research is a hard task. However, once the genes responsible for producing the compound are identified, they can potentially be transferred into microorganisms such as yeast or bacteria and will be a great breakthrough in human lives. With the right genes, these microscopic organisms could produce compounds more efficiently and sustainably than harvesting plants alone.

The discovery highlights something profound about plants themselves. Silent, still, and a master chemist and genetic engineers, refining the molecular complexity across millions of years of evolution. That scientists have yet to explore. Mitraphylline is only one example. One of tools for improving medicine, and understanding the remarkable chemistry written into plant DNA.

The battle against cancer is far from over. But somewhere in the green of the natural world, the plants already have the blueprint, ready to be decoded.